Health Condition 1: null- Vitiligo
Conditions
Interventions
Intervention1: Individualized homoeopathic medicines in centesimal potencies: A singe dose comprised of a single drop of the individualized homoeopathic medicine prepared with 83.1% ethanol taken in 5
Sponsors
Mahesh Bhattacharyya Homeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 5 yrs to 80 yrs 2. Both sexes 3. Giving written informed consent to join the study 4. VETF stage 1 & 2, spread (+1) to (-1), extent any. 5. VASI residual depigmentation 25-75%; units any. 6. Patients already undergoing regular oral/topical conventional therapy for vitiligo, provided the medications are stopped completely for at last 1 month prior registering for the study Patients on life-saving conventional drug therapies, e.g. anti-diabetics, anti-hypertensives, thyroid drugs etc. for co-morbidities under control, will be continued.
Exclusion criteria
Exclusion criteria: 1. VETF stage 0 and 3 2. VASI residual depigmentation 100%, 90% and 10% 3. Uncontrolled, unevaluated and/or complicated diabetes mellitus, hypertension, and other co-morbidities 4. Cases with other systemic unevaluated or uncontrolled diseases like cardiovascular, renal, gastro-intestinal, endocrinal, gynecological diseases etc. or systemic infections affecting quality of life or on other treatment therapies 5. Pregnancy, lactation and likelihood of pregnancy 6. Not giving consent to join the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vitiligo Area Scoring Index (VASI)Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatological Life Quality Index (DLQI)Timepoint: 6 months;Vitiligo European Task Force (VETF)Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactSubhasish Ganguly
Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Govt. of West Bengal
Outcome results
None listed